首页>
外国专利>
COMBINATION OF TRANSMEMBRANAKTIVATOR AND CALCIUM MODULATOR AND cyclophilin-LIGAND INTERAKTOR (TACI) AND ANTI-CD20 MEANS FOR TREATMENT OF AUTO-IMMUNE DISEASE
COMBINATION OF TRANSMEMBRANAKTIVATOR AND CALCIUM MODULATOR AND cyclophilin-LIGAND INTERAKTOR (TACI) AND ANTI-CD20 MEANS FOR TREATMENT OF AUTO-IMMUNE DISEASE
展开▼
机译:跨膜活化剂和钙调节剂与亲环蛋白配体相互作用剂(TACI)和抗CD20的组合治疗自体免疫性疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
A therapeutically effective amount of an extracellular domain of a transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) polypeptide comprising a secreted form of SEQ ID NO:23 and an anti-CD-20 agent comprising rituximab, for use in reducing B cell numbers in a mammal, wherein said therapeutically effective amount results in a synergistic reduction in the number of memory B cells.
展开▼
机译:治疗有效量的跨膜激活剂和钙调节剂与亲环蛋白配体相互作用物(TACI)多肽的胞外域,其包含分泌形式的SEQ ID NO:23和包含利妥昔单抗的抗CD-20剂,用于还原B哺乳动物中的细胞数目,其中所述治疗有效量导致记忆B细胞数目的协同减少。
展开▼